Ananda M. Chakrabarty is an Indian-American microbiologist, scientist, and researcher, most notable for his work in directed evolution and his role in developing a genetically engineered organism using plasmid transfer while working at GE.
National Institutes of Health Study Sections
American Society for Microbiology 1966
Einstein Institute for Science, Health and the Courts Board of Directors
National Academy of Sciences Board on Biology
National Research Council Committee on Biotechnology
NATO Industrial Advisory Group
Currently, his lab is working on elucidating the role of bacterial cupredoxins and cytochromes in cancer regression and arresting cell cycle progression. These proteins have been formerly known for their involvement in bacterial electron transport. He has isolated a bacterial protein, azurin, with potential antineoplastic properties. He has expanded his lab's work to include multiple microbiological species, including Neisseria, Plasmodia, and Acidithiobacillus ferrooxidans. In 2001, Prof. Chakrabarty founded a company, CDG Therapeutics, (incorporated in Delaware) which holds proprietary information related to five patents generated by his work at the University of Illinois at Chicago. The University of Illinois owns the rights to the patents but has issued exclusive licences to CDG Therapeutics.
Ananda M. Chakrabarty - interesting facts about
No replies to this topic